Novo Nordisk Down 1.1% Since BofA/Merrill Downgraded One Week Ago (NVO)
August 16, 2016 at 01:04 AM EDT
One week ago Novo Nordisk (NYSE:NVO) was downgraded from Buy to Neutral at BofA/Merrill. The stock closed at $46.60, which is 1.1% lower than the price one week ago...
